These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26550804)

  • 1. Reducing genomic instability in iPSCs.
    Ruiz S; Fernandez-Capetillo O
    Oncotarget; 2015 Oct; 6(33):34045-6. PubMed ID: 26550804
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic stability during cellular reprogramming: Mission impossible?
    von Joest M; Búa Aguín S; Li H
    Mutat Res; 2016 Jun; 788():12-6. PubMed ID: 26851988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.
    Lu J; Li H; Baccei A; Sasaki T; Gilbert DM; Lerou PH
    Stem Cells Dev; 2016 May; 25(9):740-7. PubMed ID: 26935587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSCs: Unstable origins?
    Mukherjee S; Thrasher AJ
    Mol Ther; 2011 Jul; 19(7):1188-90. PubMed ID: 21720379
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
    Yoshihara M; Hayashizaki Y; Murakawa Y
    Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Obstacles to Clinical Translation of iPSCs.
    Tapia N; Schöler HR
    Cell Stem Cell; 2016 Sep; 19(3):298-309. PubMed ID: 27452174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells.
    Gómez-Cabello D; Checa-Rodríguez C; Abad M; Serrano M; Huertas P
    Stem Cell Reports; 2017 Feb; 8(2):432-445. PubMed ID: 28065643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication.
    Paniza T; Deshpande M; Wang N; O'Neil R; Zuccaro MV; Smith ME; Madireddy A; James D; Ecker J; Rosenwaks Z; Egli D; Gerhardt J
    J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32673399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.
    Quinlan AR; Boland MJ; Leibowitz ML; Shumilina S; Pehrson SM; Baldwin KK; Hall IM
    Cell Stem Cell; 2011 Oct; 9(4):366-73. PubMed ID: 21982236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of Pluripotency-Specific microRNA Signatures Is Not Essential to Generate Inducible Pluripotent Stem Cells.
    Skamagki M; Zhang C; Liu Z; Li H; Zhao R; Kim K
    Cell Reprogram; 2020 Feb; 22(1):1-2. PubMed ID: 32011920
    [No Abstract]   [Full Text] [Related]  

  • 11. Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells.
    Ruiz S; Lopez-Contreras AJ; Gabut M; Marion RM; Gutierrez-Martinez P; Bua S; Ramirez O; Olalde I; Rodrigo-Perez S; Li H; Marques-Bonet T; Serrano M; Blasco MA; Batada NN; Fernandez-Capetillo O
    Nat Commun; 2015 Aug; 6():8036. PubMed ID: 26292731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
    Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
    Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: induced pluripotency by defined factors: prey of oxidative stress.
    Qi S; Fang Z; Wang D; Menendez P; Yao K; Ji J
    Stem Cells; 2015 May; 33(5):1371-6. PubMed ID: 25594616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells: the pursuit of genomic stability.
    Wyles SP; Brandt EB; Nelson TJ
    Int J Mol Sci; 2014 Nov; 15(11):20948-67. PubMed ID: 25405730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.
    Casamassa A; Ferrari D; Gelati M; Carella M; Vescovi AL; Rosati J
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.
    Lu J; Li H; Hu M; Sasaki T; Baccei A; Gilbert DM; Liu JS; Collins JJ; Lerou PH
    Cell Rep; 2014 Apr; 7(1):70-8. PubMed ID: 24685138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic instability during reprogramming by nuclear transfer is DNA replication dependent.
    Chia G; Agudo J; Treff N; Sauer MV; Billing D; Brown BD; Baer R; Egli D
    Nat Cell Biol; 2017 Apr; 19(4):282-291. PubMed ID: 28263958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.